VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage ; volume:13 ; number:1 ; day:29 ; month:6 ; year:2016 ; pages:1-14 ; date:12.2016
Journal of neuroinflammation ; 13, Heft 1 (29.6.2016), 1-14, 12.2016
- Urheber
-
Abad, Catalina
- Beteiligte Personen und Organisationen
-
Jayaram, Bhavaani
Becquet, Laurine
Wang, Yuki
O’Dorisio, M Sue
Waschek, James A.
Tan, Yossan-Var
SpringerLink (Online service)
- DOI
-
10.1186/s12974-016-0626-3
- URN
-
urn:nbn:de:1111-201607019830
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abad, Catalina
- Jayaram, Bhavaani
- Becquet, Laurine
- Wang, Yuki
- O’Dorisio, M Sue
- Waschek, James A.
- Tan, Yossan-Var
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 198
Exhibit 136
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 198
Exhibit 136
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 198